论文部分内容阅读
自体造血干细胞(auto-HSC)移植治疗淋巴瘤的疗效已得到肯定,但仍有较高的复发率。为了减少复发,许多临床学家进行了较多的有益探索。我们在进行自体HSC前进行了7次包含CD20单克隆抗体方案的常规剂量化疗,最大限度地降低体内肿瘤细胞负荷,达到体内净化的目的。现将我们完成的自
The efficacy of autologous hematopoietic stem cell (auto-HSC) transplantation in the treatment of lymphoma has been affirmed, but there is still a high recurrence rate. In order to reduce recurrence, many clinicians conducted more useful exploration. We conducted seven regular doses of chemotherapy with the CD20 monoclonal antibody regimen prior to autologous HSC to minimize tumor cell burden in vivo for the purpose of in vivo decontamination. Now we have done it